Susan L. Ettinger

Vancouver, BC, Canada

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications

Correction: Heat shock protein 27 confers resistance to androgen ablation and chemotherapy in prostate cancer cells through eIF4E.

Correction: Heat shock protein 27 confers resistance to androgen ablation and chemotherapy in prostate cancer cells through eIF4E.

Journal: Oncogene
Published: August 07, 2025

Editorial Expression of Concern: Heat shock protein 27 confers resistance to androgen ablation and chemotherapy in prostate cancer cells through eIF4E.

Editorial Expression of Concern: Heat shock protein 27 confers resistance to androgen ablation and chemotherapy in prostate cancer cells through eIF4E.

Journal: Oncogene
Published: April 10, 2025

Targeting MCT4 to reduce lactic acid secretion and glycolysis for treatment of neuroendocrine prostate cancer.

Targeting MCT4 to reduce lactic acid secretion and glycolysis for treatment of neuroendocrine prostate cancer.

Journal: Cancer medicine
Published: January 10, 2018

Metabolic heterogeneity signature of primary treatment-naïve prostate cancer.

Metabolic heterogeneity signature of primary treatment-naïve prostate cancer.

Journal: Oncotarget
Published: January 20, 2017

Clusterin knockdown sensitizes prostate cancer cells to taxane by modulating mitosis.

Clusterin knockdown sensitizes prostate cancer cells to taxane by modulating mitosis.

Journal: EMBO molecular medicine
Published: May 21, 2016

Inhibition of endoplasmic reticulum chaperone protein glucose-regulated protein 78 potentiates anti-angiogenic therapy in renal cell carcinoma through inactivation of the PERK/eIF2α pathway.

Inhibition of endoplasmic reticulum chaperone protein glucose-regulated protein 78 potentiates anti-angiogenic therapy in renal cell carcinoma through inactivation of the PERK/eIF2α pathway.

Journal: Oncotarget
Published: August 03, 2015

Cellular Adaptation to VEGF-Targeted Antiangiogenic Therapy Induces Evasive Resistance by Overproduction of Alternative Endothelial Cell Growth Factors in Renal Cell Carcinoma.

Cellular Adaptation to VEGF-Targeted Antiangiogenic Therapy Induces Evasive Resistance by Overproduction of Alternative Endothelial Cell Growth Factors in Renal Cell Carcinoma.

Journal: Neoplasia (New York, N.Y.)
Published: July 19, 2015

Targeting Integrin-Linked Kinase Suppresses Invasion and Metastasis through Downregulation of Epithelial-to-Mesenchymal Transition in Renal Cell Carcinoma.

Targeting Integrin-Linked Kinase Suppresses Invasion and Metastasis through Downregulation of Epithelial-to-Mesenchymal Transition in Renal Cell Carcinoma.

Journal: Molecular cancer therapeutics
Published: September 10, 2014

Hiding in plain view: genetic profiling reveals decades old cross contamination of bladder cancer cell line KU7 with HeLa.

Hiding in plain view: genetic profiling reveals decades old cross contamination of bladder cancer cell line KU7 with HeLa.

Journal: The Journal of urology
Published: March 04, 2013

IGF2 increases de novo steroidogenesis in prostate cancer cells.

IGF2 increases de novo steroidogenesis in prostate cancer cells.

Journal: Endocrine-related cancer
Published: January 16, 2013
Showing 1-10 of 10

Last Updated: 09/26/2026